首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Analyses of the efficacy of percutaneous kyphoplasty and alendronate sodium on thoracolumbar vertebral fracture and the risk factors of fracture
【2h】

Analyses of the efficacy of percutaneous kyphoplasty and alendronate sodium on thoracolumbar vertebral fracture and the risk factors of fracture

机译:经皮椎体后凸成形术和阿仑膦酸钠治疗胸腰椎椎体骨折的疗效及危险因素分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study investigated the efficacy of percutaneous kyphoplasty and alendronate sodium on thoracolumbar vertebral fracture, and the risk factors leading to the recurrence of fracture. In the present study, a total of 80 patients with thoracolumbar vertebral fracture who were admitted to the Affiliated Jiangyin Hospital of Southeast University Medical College between January 2014 and March 2016 for combination treatment of percutaneous kyphoplasty and alendronate sodium were enrolled. According to the recurrence of fracture, the patients were divided into two groups, the observation group (patients with fracture recurrence, n=40) and control group (patients with no fracture recurrence, n=40). All patients participated in a 1-year follow-up. The recurrence of fracture and the site of fracture were identified through the clinical symptoms and examination of the spine using magnetic resonance imaging. In addition, comparisons of the time of alleviation in numbness of lower limb and that in pains in waist and legs were carried out. Furthermore, statistics on the adverse reactions during intervention in the two groups were also collected; changes in visual analogue scale (VAS) and Oswestry Disability Index (ODI) of pains at different time points in two groups were also observed. One-way analysis and multivariate analysis were performed to identify the relevant risk factors. Alleviation time in numbness of lower legs in patients of the control group was significantly earlier than that in the observation group (P<0.05) and the alleviation time in pains of the waist and legs of patients in the control group was also significantly earlier than that in the observation group (P<0.05). Furthermore, the incidence rates of abdominal pain, diarrhea, constipation and hypocalcemiain in the control group were also significantly lower compared with those in the observation group (P<0.05). One week, one month and one year after operation, the scores of VAS of pains and ODI in the control group were significantly lower compared with those in the observation group in the same period (P<0.05). Lower preoperative bone density and exosmosis of bone cement in treatment were the independent risk factors leading to the recurrence of fracture. For patients with thoracolumbar vertebral fracture who received the combination treatment of percutaneous kyphoplasty and alendronate sodium, there underlies an important correlation between the recurrence rate of fracture and the preoperative bone density as well as the exosmosis of bone cement in operation.
机译:本研究探讨了经皮椎体后凸成形术和阿仑膦酸钠对胸腰椎椎体骨折的疗效,以及导致骨折复发的危险因素。在本研究中,我们纳入了2014年1月至2016年3月在东南大学医学院附属江阴医院接受经皮椎体后凸成形术和阿仑膦酸钠联合治疗的80例胸腰椎椎体骨折患者。根据骨折复发情况将患者分为两组,观察组(骨折复发患者,n = 40)和对照组(无骨折复发患者,n = 40)。所有患者均参加了为期1年的随访。通过临床症状和使用磁共振成像检查脊柱来确定骨折的复发和骨折的部位。另外,比较了下肢麻木缓解时间和腰腿疼痛的时间。此外,还收集了两组干预期间不良反应的统计数据。还观察了两组在不同时间点的疼痛的视觉模拟量表(VAS)和Oswestry残疾指数(ODI)的变化。进行单向分析和多变量分析以识别相关的危险因素。对照组患者小腿麻木的缓解时间明显早于观察组(P <0.05),对照组患者腰腿疼痛的缓解时间也明显早于观察组。观察组(P <0.05)。此外,对照组的腹痛,腹泻,便秘和低钙血症的发生率也明显低于观察组(P <0.05)。术后1周,1个月和1年,对照组的VAS评分和ODI评分明显低于同期观察组(P <0.05)。术前降低骨密度和骨水泥渗透是导致骨折复发的独立危险因素。对于接受经皮椎体后凸成形术和阿仑膦酸钠联合治疗的胸腰椎椎体骨折患者,骨折的复发率与术前骨密度以及手术中骨水泥的渗透之间存在重要的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号